11β-hydroxysteroid dehydrogenase type 1 as a predictive biomarker for glucocorticoid treatment response in inflammatory myopathies

Folia Neuropathologica · Published 2026-01-01 · DOI 10.5114/fn.2026.163679

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.5114/fn.2026.163679

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Cepharanthine enhances functional recovery in spinal cord injury by attenuating NLRP3 inflammasome activation through the Nrf2/HO-1 and NF-κB pathways · Folia Neuropathologica · 2026 · Same journal
• Tumor-suppressive role of miR-129-5p in gliomas through downregulation of CCND1 · Folia Neuropathologica · 2025 · Same journal
• Immune reconstitution for the treatment of myasthenia gravis – the place of cladribine · Folia Neuropathologica · 2025 · Same journal
• TREM2/DAP12 complex promotes proliferation and invasion of glioma cells via the PI3K-AKT signaling pathway · Folia Neuropathologica · 2025 · Same journal
• Efficacy of Buyang Huanwu Decoction in treating acute ischemic stroke based on the neurovascular unit · Folia Neuropathologica · 2025 · Same journal
• Therapeutic effect and mechanism of bone marrow mesenchymal stem cell-derived exosomes on traumatic brain injury through the ERK signaling pathway · Folia Neuropathologica · 2026 · Same journal
• L1 modulates protein kinase D1 (PKD1) phosphorylation during H2O2-induced cell senescence · Folia Neuropathologica · 2025 · Same journal
• Nab-paclitaxel: A revolution in the nano-therapeutic approach to IDH-wildtype glioblastoma · Folia Neuropathologica · 2025 · Same journal
• Expression of components involved in cholesterol homeostasis maintenance during experimental autoimmune encephalomyelitis in rat spinal cord · Folia Neuropathologica · 2024 · Same journal
• Treatment update for autoimmune/immune-mediated central nervous system diseases · Folia Neuropathologica · 2025 · Same journal